SCHEMBL2084997

SCHEMBL2084997

Cc1cnc(CNCc2ncccc2N2CCOCC2)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 3/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
SCN9A Q15858 1/20 0.39
NCF1 P14598 1/20 0.38
HPGD P15428 1/20 0.37
BRD4 O60885 1/20 0.36
BRD9 Q9H8M2 1/20 0.36
PKM P14618 2/20 0.36
PIK3CB P42338 2/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2084491 0.88 CNR2 (0.40) TSHRMEN1KMT2ANPSR1LMNA
SCHEMBL2084297 0.80 CXCR4 (0.35) TSHRMEN1KMT2ANPSR1LMNA
SCHEMBL12935306 0.77 CXCR4 (0.51) CHRM2CHRM4CHRM5CYP2D6CHRM1
SCHEMBL2085278 0.76 ROCK1 (0.39) MEN1KMT2ALMNAALDH1A1CYP3A4
SCHEMBL24801822 0.73 SMN1; SMN2 (0.42) ALDH1A1CYP1A2CYP2C9EGLN1SCN9A
SCHEMBL2086487 0.72 CXCR4 (0.38) ALDH1A1CXCR4
SCHEMBL3645849 0.70 ALDH1A1 (0.45) MEN1KMT2ALMNAALDH1A1CYP3A4
SCHEMBL3647188 0.70 ALDH1A1 (0.45) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL2080974 0.70 SMN1; SMN2 (0.42) MEN1KMT2ALMNAALDH1A1CYP1A2
SCHEMBL2082333 0.69 CXCR4 (0.37) CHRM2CHRM4CHRM5CYP2D6CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 TSHR 941/4885MEN1 4472/4885KMT2A 4082/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 TSHR 491/4885MEN1 4609/4885KMT2A 2950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.